Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Chengkang Pharmaceutical is a comprehensive pharmaceutical enterprise based in Jining, China, specializing in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates a modern manufacturing base in the Jiaxiang County Industrial Park, which is designed to meet stringent national Good Manufacturing Practice (GMP) standards. Its product portfolio is primarily focused on high-prevalence therapeutic areas, including cardiovascular health, metabolic disorders, and anti-infectives. Key commercial products include widely used generics such as Amlodipine Besylate for hypertension and Metformin Hydrochloride for diabetes management. By integrating API synthesis with finished drug production, the company maintains a competitive position in the global pharmaceutical supply chain, serving both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Chengkang Pharmaceutical.